London-based healthcare AI company Huma has said that it raised $80 million in its Series D funding round to further expand the reach of the platform.
With this round, the company has now raised over $300 million.
The round saw the participation of new and existing strategic and financial investors, including AstraZeneca, Hat Technology Fund 4 by HAT SGR, HV Fund by Hitachi Ventures and Leaps by Bayer and others.
HSBC Bank acted as an advisor to Huma during the fundraise, according to the company.
“We are here to accelerate the adoption of digital and AI across care and research, and we do that by making the building of digital health solutions for care and research easy. We like to think of Huma Cloud Platform much like Shopify but for digital health instead of e-commerce,” Dan Vahdat, Founder and CEO of Huma, said in a statement.
“We believe that when digital and AI are scaled, they become affordable for both the poor and the rich. This will help us transition medicine from being reactive to proactive,” he added.
Alongside its Series D funding, the healthtech firm also launched ‘Huma Cloud Platform’ – a technology ecosystem designed not only to support the company’s own digital health initiatives, but also to empower others to launch and scale their projects efficiently.
With its Huma Cloud Platform and the regulatory foundation that it is built on, the company said that it aims to reduce the time it takes to develop and launch digital health projects at scale from years to as little as a few days.
Huma has also partnered with Google and others to develop new AI models that could enable its Cloud Platform users to care for many times more patients with less work, the company mentioned.
The platform has been used to engage and screen over 35 million individuals, with 1.8 million active users across its products in over 70 countries.